AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02953184 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Modified Radical Mastectomy
Description: Patients will undergo Modified Radical Mastectomy if she does not keep her breast after 8 cycles of chemotherapy
Study NCT02953184 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Modified Radical Mastectomy
Description: Patients will undergo Modified Radical Mastectomy if she does not keep her breast after 8 cycles of chemotherapy
Study NCT02953184 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sentinel Lymph Node Biopsy（SLNB）
Description: Patients will undergo Sentinel Lymph Node Biopsy（SLNB） if the evaluation of lymph node are negative after 8 cycles of chemotherapy
Study NCT02953184 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Sentinel Lymph Node Biopsy（SLNB）
Description: Patients will undergo Sentinel Lymph Node Biopsy（SLNB） if the evaluation of lymph node are negative after 8 cycles of chemotherapy
Study NCT04275076 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Holmium laser enucleation of the prostate versus bipolar transurethral enucleation of the prostate in management of benign prostatic hyperplasia
Description: comparison between 2 energy sources of enucleation in management of benign prostatic hyperplasia, holmium laser versus bipolar energy source in trans-urethral enucleation of the prostate
Study NCT00051714 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family-Based Preventive Intervention
Study NCT03534882 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Discontinuation of topical prostaglandin analogue therapy
Description: Participants are asked to discontinue their prostaglandin analogue eye drops for the designated time period (42 days)
Study NCT00881361 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: ultrasound imaging
Study NCT01008618 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fentanyl
Description: One-day adhesive transdermal patch containing fentanyl 12.5 to 50 mcg/hr applied to chest, abdomen, upper arm or thigh and replaced every day.
Study NCT01008618 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo patch indistinguishable from one-day adhesive transdermal patch containing fentanyl 12.5 to 50 mcg/hr applied to chest, abdomen, upper arm or thigh and replaced every day.
Study NCT00888147 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Intervention: Fiber containing tube feeding formula
Description: This group will be prescribed adequate calories, protein and fluid using a formula that contains fiber.
Study NCT03534050 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: postoperative adjuvant RT
Study NCT04429464 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AcQBlate Force Sensing Ablation Catheter
Description: Confirmation that the AcQBlate Force System is safe and effective for the treatment of atrial arrhythmias
Study NCT04142216 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Chewing Gum
Description: The patients will chew one piece of regular chewing gum six times in a day and feeling of thirst for ten minutes for three months.
Study NCT04435314 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nitazoxanide
Description: Subjects will receive nitazonanide 600 mg TID for 7 days
Study NCT04435314 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subjects will receive placebo TID for 7 days.
Study NCT02268643 — intervention group
Intervention type: OTHER
Intervention: ultrasound plus clinical breast examination
Description: all the participants will be required to fill risk factor questionaires and then be screened with ultrasound plus physical examination every year
Study NCT02758990 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Coffee
Description: Subjects will be asked to increase coffee intake by drinking 2 cups (177 mL each) of coffee per day.
Study NCT06263036 — intervention group
Intervention type: OTHER
Intervention: Men
Description: Laryngeal cartilages
Study NCT06263036 — intervention group
Intervention type: OTHER
Intervention: Women
Description: Laryngeal cartilages
Study NCT02785328 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: memory evaluation at V1 and V2 (with treatment)
Description: Overnight episodic and procedural memory consolidation performance will be assessed at V1 and V2. The performance will be correlated with sleep data, diurnal neuropsychological assessment and academic performance. The children receive drug treatment (BECTS and Narcolepsy) or surgical (OSA) as part of their routine care.
Study NCT00983359 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: Patients undergo conformal stereotatic radiation therapy QD (every day) over 5 days.
Study NCT02637024 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: APBI: 30 Gy
Description: 30 Gy in 5 fractions of 6 Gy, delivered daily, Monday to Friday, over a period of 5-8 days. A multiple small field 3D-conformal or intensity modulated radiation therapy (IMRT) technique will be used.
Study NCT02637024 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: APBI: 27.5 Gy
Description: 27.5 Gy in 5 fractions of 5.5 Gy, delivered daily, Monday to Friday, over a period of 5-8 days. A multiple small field 3D-conformal or intensity modulated radiation therapy (IMRT) technique will be used.
Study NCT01841918 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Avian Flu Vaccine
Study NCT01841918 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Avian Flu Vaccine
Study NCT01113554 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: questionnaire administration
Study NCT01113554 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: exercise intervention
Study NCT01113554 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: quality-of-life assessment
Study NCT01113554 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: survey administration
Study NCT01113554 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: management of therapy complications
Study NCT01113554 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: psychosocial assessment and care
Study NCT03111017 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise Training
Description: HFpEF patients randomized to either 16 weeks of exercise training or attention control group.
Study NCT01240408 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HOPE
Description: 10 mg lenvatinib (1x10 mg lenvatinib capsule) with food
Study NCT03690596 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: NRT + QuitBuddy
Description: QuitBuddy treatment app and 1 month supply of 4 mg nicotine lozenge
Study NCT01240408 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HOPE
Description: 10 mg lenvatinib (1x10 mg lenvatinib capsule) without food
Study NCT03690596 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: NRT + QuitBuddy-Recall
Description: QuitBuddy-Recall treatment app and 1 month supply of 4 mg nicotine lozenge
Study NCT03690596 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as Usual
Description: 1 month supply of 4 mg nicotine lozenge
Study NCT02980874 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: suprachoroidal sham
Description: suprachoroidal sham procedure
Study NCT02980874 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IVT aflibercept
Description: 2 mg intravitreal injection of aflibercept
Study NCT02980874 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: IVT aflibercept
Description: 2 mg intravitreal injection of aflibercept
Study NCT00793182 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ioversol 320 mgI/mL
Description: 125 mL of Ioversol administered in the vein
Study NCT00793182 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Iodixanol 320 mgI/mL
Description: 125 mL of Iodixanol administered in the vein
Study NCT03930420 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Connect to Wellness
Description: The research team will train LHD staff and offer them technical assistance to work with small worksites. LHD staff will be trained to deliver the Connect to Wellness program to worksites. Connect to Wellness is a program to disseminate EBIs to small worksites. Worksites receive guidance about EBIs and ongoing implementation assistance from a trained interventionist. In this study, LHD staff will be the interventionists. Worksites participating in Connect to Wellness complete three phases of activities, Assessment, Recommendations, and Implementation. LHD staff will receive Connect to Wellness intervention materials, multiple webinars delivered in real-time, access to a comprehensive intervention and training platform with features that allow them to connect with each other and with research staff, and group technical assistance calls to support their ability to recruit worksites in their communities and deliver Connect to Wellness to these worksites.
Study NCT03930420 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Connect to Wellness
Description: The research team will train LHD staff and offer them technical assistance to work with small worksites. LHD staff will be trained to deliver the Connect to Wellness program to worksites. Connect to Wellness is a program to disseminate EBIs to small worksites. Worksites receive guidance about EBIs and ongoing implementation assistance from a trained interventionist. In this study, LHD staff will be the interventionists. Worksites participating in Connect to Wellness complete three phases of activities, Assessment, Recommendations, and Implementation. LHD staff will receive Connect to Wellness intervention materials, multiple webinars delivered in real-time, access to a comprehensive intervention and training platform with features that allow them to connect with each other and with research staff, and group technical assistance calls to support their ability to recruit worksites in their communities and deliver Connect to Wellness to these worksites.
Study NCT01226212 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Synbiotic (Synergy 1/B. longum)
Description: Combination of a prebiotic Synergy 1 and a probiotic Bifidobacterium longum
Study NCT01226212 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: maltodextrose
Study NCT02785328 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: memory evaluation at V1 (without treatment)
Description: Overnight episodic and procedural memory consolidation performance will be assessed at V1. The performance will be correlated with sleep data, diurnal neuropsychological assessment and academic performance.
Study NCT02785328 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: memory evaluation at V1 and V2 (without treatment)
Description: Overnight episodic and procedural memory consolidation performance will be assessed at V1 and V2. The performance will be correlated with sleep data, diurnal neuropsychological assessment and academic performance.
Study NCT01507701 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clonidine
Description: 50 micrograms twice a day for 14 days; thereafter 25 microgram clonidine twice a day for 7 days; thereafter discontinuation.
Study NCT01861847 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 7-Keto Dehydroepiandrosterone
Description: 7-Keto Dehydroepiandrosterone, 100 mg capsules given orally twice daily for 4 weeks in one of the two intervention phases, dependent on randomization assignment.
Study NCT01861847 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo, 100 mg capsules given orally twice daily for 4 weeks in one of the two intervention phases, dependent on randomization assignment.
Study NCT05361265 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: fetal movement counting
Description: pregnant women were trained about fetal movements and fetal movement counting was taught. Pregnant women were asked to perform ten fetal movements by counting once a day. In the application of the study, it was ensured that the pregnant women in the experimental group performed fetal movement counting for at least four to six weeks. In this context, pregnant women were called every week to monitor and to motivate them to continue the counting.
Study NCT02307838 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Assessments arm
Description: Protocol required assessments not provided in standard of care
Study NCT04008108 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Activity sensor
Description: Activity sensor worn on the wrist during 7 days, 24h/24 to evaluate physical activity of patient (measured by the number of step per day) before and after Artificial Urinary Sphincter Implantation.
Study NCT02679443 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Folate and B12
Description: Vitamin (folate and B12) supplementation started simultaneously with initiation of chemotherapy (within 24 hours of initiation of chemotherapy). The only difference from the delayed (no-intervention) arm is the timing of initiation of vitamin supplementation. Dose and mode of administration of vitamin B12 and folate supplementation remain similar in both arms.
Study NCT00879463 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Brain tissue oxygen saturation monitoring
Description: Brain tissue oxygen saturation monitoring with infrared spectrophotoscopy
Study NCT04027101 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Baricitinib
Description: patient will take a tablet of 4 mg/d during 12 weeks and then 2 mg/d during 12 weeks if the patient achieves PMR-AS≤ 10 at week 12
Study NCT04027101 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebos
Description: patient will take a tablet of 4 mg/d during 12 weeks and then 2 mg/d during 12 weeks if the patient achieves PMR-AS≤ 10 at week 12
Study NCT01932281 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: SierraSil
Description: SierraSil is a natural, mineral supplement currently used to improve joint health and function.
Study NCT01932281 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Sugar pill manufactured to mimic SierraSil 667 mg capsule
Study NCT03421574 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MR-guided Focused Ultrasound
Description: Focused Ultrasound allows for non-invasive thermal ablation of soft tissue virtually anywhere in the body. Treatment begins by acquiring a series of magnetic resonance (MR) images of the target tissue. The physician then reviews the images on the system workstation, identifies the target, delineates treatment contours, and reviews the treatment plan. Therapy planning software calculates the parameters required to effectively treat (e.g. ablate) the defined region. During treatment, the patient wears a helmet equipped with multiple sources of ultrasound which generate a point of focused energy, called a sonication. The sonication raises the tissue temperature within a well-defined region, causing a thermal coagulation effect.
Study NCT00879463 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transfusion according to the anesthesiologist's judgement
Description: Transfusion if hemoglobin is between 5.5-7 mg/dl
Study NCT01628419 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health intervention
Description: physical activity program at the workplace - once a week with a certified trainer. (The program will include: aerobic exercises as well as resistance exercises). The employees will encourage to perform two additional workouts during the week.~Nutritional counseling for the kitchen staff Lectures - lectures will be given at each worksite on different topics: physical activity, nutrition, sleeping behaviour, mental aspects.
Study NCT01542229 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Prolonged Exposure for PTSD (PE) + Treatment as Usual (TAU)
Description: 12 weekly sessions of Prolonged Exposure in addition to Treatment As Usual
Study NCT01542229 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treatment As Usual (TAU)
Description: Treatment as usual (TAU) will receive support services through the VA potentially inclusive of case management, psychotropic medication management, and/or supportive counseling
Study NCT04597398 — intervention group
Intervention type: DEVICE
Intervention: Evaluation of blood flow with indocyanine green
Study NCT03456895 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Light perception
Description: We will be using Wi-Fi/IP programmable LED lighting systems that will replace conventional lighting systems and may be in canned lights, spot lights, light chains or table lights. These lighting systems can be fully controlled by web based applications on smart phones tablets and computer systems and can be combined with input systems such as switches, motion detection or voice activated. Differences in lighting perception will be explored by varying lighting color and brightness.
Study NCT03456895 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sound perception
Description: We will be using Wi-Fi/Bluetooth addressable sound systems that will be linked with sound sources such as media players on smart devices or computer systems. Differences in sound perception will be explored by varying sound types (i.e. different music types, ambient noise, etc.).
Study NCT03456895 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Smell perception
Description: We will explore the use of consumer grade ventilation systems that can be equipped to distribute packaged scents. Differences in smell perception will be explored by varying the types of scents.
Study NCT03456895 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vibration perception
Description: We will explore the use of chairs or blankets that enable subjects to perceive vibrations. An initial implementation will be the use of on relaxing/massage chair that enables the experience of vibration sensation in the back or leg area. We may use also potentially vibration blankets in the arm or neck area. Differences in vibration perception will be explored by varying the location, frequency, etc. of vibrations with the subject being placed in a chair on an imaging table/bed.
Study NCT03456895 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Voice activation
Description: We will explore the use and linkage of voice activation system such as Amazon Echo, Google home or similar devices. Some participants may be asked to use voice activations to verbally select and/or change the environmental settings according to their preferences. We are evaluating the feasibility of voice activation with the imaging environment.
Study NCT02870400 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN2477
Description: Participants will receive ascending doses of REGN2477
Study NCT02870400 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Participants will receive matching placebo
Study NCT00598624 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treosulfan IV
Description: Treosulfan i.v.: 14 g/m²/d from day -6 to day -4
Study NCT01297374 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: physical activities, dietician counseling and behavioral changes
Description: One arm receive an schedule for physical activities. One arm receive a diet prescription. One arm receive general guidance on diet, physical activity and behavioral changes
Study NCT02751359 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cannabidiol
Description: 200, 400, or 800 mg Cannabidiol
Study NCT02751359 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 0 mg Cannabidiol
Study NCT00885014 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CBT
Description: Telephone cognitive-behavioral therapy
Study NCT00885014 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: EAP
Description: Employees Assistance Program
Study NCT00885014 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: EAP
Description: Employees Assistance Program
Study NCT03738514 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 5% fluorocalcium phosphosilicate dentifrice
Description: dentifrice containing 5% fluorocalcium phosphosilicate and VAS score assessed at Baseline, 2 weeks, 6 weeks
Study NCT03738514 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: 5% potassium nitrate dentifrice
Description: 5% potassium nitrate dentifrice and VAS score assessed at Baseline, 2weeks, 6 weeks.
Study NCT03738514 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo dentrifice
Description: placebo dentifrice and VAS score assessed at Baseline, 2weeks, 6 weeks
Study NCT01506544 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydroxyurea
Description: 20mg/kg of Hydroxyurea or the patient's standard daily dose
Study NCT01506544 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hydroxyurea
Description: 20mg/kg of Hydroxyurea or the patient's standard daily dose
Study NCT03420365 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Description: 30 minutes of either aerobic, or balance and coordination, or reading magazines